CN110743004A - Astaxanthin direct drinking powder composition with whitening function and preparation method and application thereof - Google Patents
Astaxanthin direct drinking powder composition with whitening function and preparation method and application thereof Download PDFInfo
- Publication number
- CN110743004A CN110743004A CN201911184890.5A CN201911184890A CN110743004A CN 110743004 A CN110743004 A CN 110743004A CN 201911184890 A CN201911184890 A CN 201911184890A CN 110743004 A CN110743004 A CN 110743004A
- Authority
- CN
- China
- Prior art keywords
- parts
- astaxanthin
- powder
- powder composition
- drink
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 82
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 66
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 66
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 66
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 66
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 66
- 230000002087 whitening effect Effects 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 230000035622 drinking Effects 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 32
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 16
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 16
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 16
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 15
- 102000008186 Collagen Human genes 0.000 claims abstract description 14
- 108010035532 Collagen Proteins 0.000 claims abstract description 14
- 229920001436 collagen Polymers 0.000 claims abstract description 14
- 239000003094 microcapsule Substances 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 8
- 239000008187 granular material Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 238000004806 packaging method and process Methods 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 235000005979 Citrus limon Nutrition 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 239000004386 Erythritol Substances 0.000 claims description 5
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 235000019414 erythritol Nutrition 0.000 claims description 5
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 5
- 229940009714 erythritol Drugs 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 4
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 102000015636 Oligopeptides Human genes 0.000 claims description 3
- 108010038807 Oligopeptides Proteins 0.000 claims description 3
- 210000000988 bone and bone Anatomy 0.000 claims description 3
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 150000003384 small molecules Chemical class 0.000 claims description 3
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 3
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 3
- 229960005055 sodium ascorbate Drugs 0.000 claims description 3
- 229940080313 sodium starch Drugs 0.000 claims description 3
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 2
- 244000248349 Citrus limon Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 6
- 230000003796 beauty Effects 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 24
- 230000000052 comparative effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 244000131522 Citrus pyriformis Species 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 2
- 244000134540 Polymnia sonchifolia Species 0.000 description 2
- 235000003406 Polymnia sonchifolia Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000013588 oral product Substances 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 244000182216 Mimusops elengi Species 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229940023486 oral product Drugs 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses an astaxanthin direct drinking powder composition with a whitening function, and a preparation method and application thereof, wherein the astaxanthin direct drinking powder composition comprises the following components in parts by weight: 3-30 parts of astaxanthin microcapsule powder, 2-20 parts of haematococcus pluvialis powder, 0.2-10 parts of collagen peptide and 0.2-5 parts of ascorbic acid; the preparation method comprises the following steps: mixing the above materials at a certain proportion, making into 60-80 mesh granules, drying, and packaging. The astaxanthin direct drinking powder composition with the whitening function achieves the effects of moistening skin and increasing the skin whitening degree by reasonably composing and matching various components, resisting oxidation, reducing free radicals, resisting saccharification, providing collagen and the like, and is suitable for people who love beauty, people with dark and dark skin, rough skin and the like; is convenient to carry and safe to eat; the raw materials are easy to obtain, the conditions and equipment required by preparation are simple, the process is simple and controllable, and the method has important practical popularization value.
Description
Technical Field
The invention belongs to the field of medicines and health-care products, and particularly relates to an astaxanthin direct drinking powder composition with a whitening function, and a preparation method and application thereof.
Background
With the rapid growth of social economy, the whitening market also grows rapidly. Based on the holding of Asian consumers in the whitening field, a plurality of brands and related products with whitening efficacy emerge in the market, and the existing whitening external application products in the market have quick effect but certain potential safety hazards. Therefore, the oral product has the functions of conditioning the body, resisting oxidation, removing free radicals and the like, thereby having the whitening effect and wide market prospect.
By orally administering antioxidant products (such as astaxanthin and ascorbic acid), dark yellow skin color and pigmentation during early aging of skin can be reduced and prevented, fine lines, mottle and erythema can be improved, pores can be shrunk, acne can be reduced, and skin metabolism can be improved.
In addition, the existing patent applications related to whitening products mainly relate to skin care products and cosmetics, while the patent of whitening health-type composition oral products is less. The Chinese patent application with the application number of 201510119657.4 discloses a beautifying and health-care drink with whitening and anti-wrinkle effects, which is prepared by processing yacon, compounding other traditional Chinese medicines such as ginger, medlar, rose, rosemary and the like, adding chitin and probiotics for fermentation, adjusting the taste with milk powder, and promoting bifidobacterium and lactobacillus fermentation to a better quantitative value through fruit oligosaccharide, chitin and xylitol of the yacon. Under the combined action of the traditional Chinese medicines and the probiotics, the health-care beverage can regulate endocrine, maintain beauty and keep young, particularly can whiten skin, lighten spots, promote skin regeneration and lighten wrinkles; chinese invention patent application with application number of 201310230185.0 discloses a Chinese medicinal composition for whitening skin and application thereof, wherein the Chinese medicinal composition is prepared from the following raw material medicaments in part by weight: the Chinese medicinal composition is prepared by crushing raw medicinal materials, sieving the raw medicinal materials with a 80-mesh sieve, wrapping the raw medicinal materials in gauze, putting the gauze in a container filled with cold boiled water, decocting the gauze until the gauze is boiled and continuously decocting the gauze for 6 to 8 hours, and has the remarkable effects of activating blood circulation and removing obstruction in channels and whitening skin.
In summary, most of the existing whitening products are external products such as cosmetics, skin care products and masks, but the whitening products are fewer in the aspect of conditioning the interior of the body, and the rare conditioning whitening products are also traditional Chinese medicine substances, have more practical product problems from easy production to side effects and the like, are not good in taking mode and taste, and are not easy to be favored by women.
So far, no report about the application of astaxanthin microcapsule powder, haematococcus pluvialis powder, collagen peptide, ascorbic acid and the like in preparing an internal product with a whitening function is found.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide an astaxanthin direct drinking powder composition with a whitening function.
The invention also aims to provide a preparation method of the astaxanthin direct drinking powder composition.
The invention also aims to provide application of the astaxanthin direct drinking powder composition.
The invention adopts the following technical scheme:
an astaxanthin direct drinking powder composition with a whitening function comprises the following components in parts by weight:
3-30 parts of astaxanthin microcapsule powder, 2-20 parts of haematococcus pluvialis powder, 0.2-10 parts of collagen peptide and 0.2-5 parts of ascorbic acid.
Preferably, the astaxanthin direct drinking powder composition with the whitening function provided by the invention comprises the following components in parts by weight:
12-22.5 parts of astaxanthin microcapsule powder, 8.5-13.2 parts of haematococcus pluvialis powder, 0.75-3.6 parts of collagen peptide and 0.35-2.5 parts of ascorbic acid.
Further preferably, the astaxanthin direct drinking powder composition with the whitening function provided by the invention further comprises the following components in parts by weight:
5-45 parts of erythritol, 3-40 parts of orange powder, 3-35 parts of resistant dextrin, 2-15 parts of lemon powder, 0.2-5 parts of citric acid and 0.04-3 parts of edible essence.
Still further preferably, the astaxanthin direct drinking powder composition with the whitening function provided by the invention comprises the following components in parts by weight:
30 parts of erythritol, 20 parts of orange powder, 20 parts of resistant dextrin, 15 parts of astaxanthin microcapsule powder, 10 parts of haematococcus pluvialis powder, 3 parts of lemon powder, 1 part of collagen peptide, 0.5 part of ascorbic acid, 0.5 part of citric acid and 0.1 part of edible essence.
The astaxanthin direct drinking powder composition with the whitening function provided by the invention comprises the following components in parts by weight:
the astaxanthin microcapsule powder consists of sodium starch octenyl succinate, haematococcus pluvialis, isomaltooligosaccharide, ascorbic acid and sodium ascorbate, wherein the content of astaxanthin is 2.1-5.5 wt%.
The collagen peptide is polypeptide and oligopeptide substances which are obtained by enzymolysis of animal bones and fur and are rich in small molecules with the molecular weight of 700-5000 Da.
The content of astaxanthin in the haematococcus pluvialis powder is 1.75-2.58 wt%.
The content of VC in the ascorbic acid is more than 95 wt%.
The invention also provides a preparation method of the astaxanthin direct drinking powder composition with the whitening function, which comprises the following steps:
mixing the above materials at a certain proportion, making into 60-80 mesh granules, drying, and packaging.
The invention also provides application of the astaxanthin direct drinking powder composition with the whitening function in preparation of foods, medicines or health-care products with the whitening function.
The astaxanthin direct drinking powder composition with the whitening function provided by the invention can be increased or reduced according to corresponding proportion during production, for example, the weight can be increased or reduced by kilogram or ton in large-scale production and by gram in small-scale production, but the weight proportion of the raw materials among the components is unchanged.
The astaxanthin direct drinking powder composition with the whitening function has the following advantages:
(1) the astaxanthin direct drinking powder product with the whitening function provided by the invention takes astaxanthin microcapsule powder, haematococcus pluvialis powder, collagen peptide and ascorbic acid as main components, so that various components are reasonably combined and shared, and the effects of moistening skin and increasing skin whitening degree are achieved by means of antioxidation, free radical reduction, saccharification resistance, collagen provision and the like, so that the product is suitable for people who love beauty, people with dark and dark skin, rough skin and the like;
(2) the astaxanthin direct drinking powder product with the whitening function is convenient to carry, safe and reliable to eat, moderate in taste and special in fragrance, and can be directly poured into the mouth for taking;
(3) the crowd experiments prove that after the astaxanthin direct drinking powder product with the whitening function is taken, the skin state is obviously improved and whitened, and the functional composition provided by the invention can effectively improve the skin color and roughness;
(4) the astaxanthin direct drinking powder product with the whitening function provided by the invention has the advantages of easily available raw materials, simple preparation conditions and equipment, simple and controllable process and very important practical popularization value.
Detailed Description
The following describes the embodiments of the present invention in further detail with reference to specific examples.
The following examples are intended to illustrate the present invention, but not to limit the scope of the invention, which is defined by the claims.
Unless otherwise specified, the test reagents and materials used in the examples of the present invention are commercially available.
The raw material sources used in the examples of the invention and the comparative examples are as follows:
the astaxanthin microcapsule powder is a product sold in the Xian Saiyang biotechnology limited company, and is prepared from sodium starch octenylsuccinate, Haematococcus pluvialis, isomaltooligosaccharide, ascorbic acid and sodium ascorbate according to the mass ratio of 5: 90: 3: 1: 1, wherein the content of astaxanthin is 4.8 wt%.
The collagen peptide is a product sold in Beijing Shengnuo biotechnology limited company, and is specifically polypeptide and oligopeptide substances which are obtained by enzymolysis of animal bones and fur and are rich in small molecules with the molecular weight of 700-5000 Da.
The astaxanthin content in the haematococcus pluvialis powder is 1.98 wt%.
The ascorbic acid used had a VC content of 97.5% by weight.
The erythritol 3, the willow orange powder, the resistant dextrin, the lemon powder, the citric acid and the edible essence are all commercially available products.
In the preparation process of the invention, the used means are all conventional technical means in the field unless otherwise specified.
Example 1
The embodiment provides an astaxanthin direct drinking powder composition with a whitening function.
1. Component (parts by weight)
2. Preparation method
Mixing the above components at a certain proportion, making into 60-80 mesh granules, drying, and packaging.
Example 2
The embodiment provides an astaxanthin direct drinking powder composition with a whitening function.
1. Component (parts by weight)
2. Preparation method
Mixing the above components at a certain proportion, making into 60-80 mesh granules, drying, and packaging.
Example 3
The embodiment provides an astaxanthin direct drinking powder composition with a whitening function.
1. Component (parts by weight)
2. Preparation method
Mixing the above components at a certain proportion, making into 60-80 mesh granules, drying, and packaging.
Comparative example 1
The embodiment provides an astaxanthin direct drinking powder composition with a whitening function.
1. Component (parts by weight)
2. Preparation method
Mixing the above components at a certain proportion, making into 60-80 mesh granules, drying, and packaging.
Comparative example 2
The embodiment provides an astaxanthin direct drinking powder composition with a whitening function.
1. Component (parts by weight)
2. Preparation method
Mixing the above components at a certain proportion, making into 60-80 mesh granules, drying, and packaging.
Functional experimental testing: in order to prove that the astaxanthin direct drinking powder composition disclosed by the embodiment of the invention has an obvious promotion effect on whitening, a test of a volunteer is selected for proving, and the specific process is as follows:
example 1
250 skin dark volunteers were randomized to diet, with 125 males and 125 females randomized into five groups of 25 males and 25 females each.
Group 1 tasted the astaxanthin drink powder composition of example 1;
group 2 tasted the astaxanthin drink powder composition of example 2;
group 3 tasted the astaxanthin drink powder composition of example 3;
group 4 tasted the astaxanthin drink powder composition of comparative example 1;
group 5 was fed the astaxanthin drink powder composition of comparative example 2.
The eating method comprises the following steps:
each group of people takes the astaxanthin direct drinking powder composition of 15g dissolved in 50-100mL of warm water every night, and the final whitening effect is counted.
The following table 1 shows the statistical results of the effect of the experimental examples of the present invention for each group of test feeders.
Table 1 statistical comparison table of whitening effect of each group of test takers in experimental example of the present invention
The results of table 1 show that the astaxanthin direct drinking powder composition provided by the embodiment of the invention can effectively promote the whitening of human body, has an effective rate of up to 100%, is suitable for beauty lovers, people with dark and dark skin, rough skin and the like, and can effectively improve the color and the roughness of the skin; the astaxanthin direct drinking powder product with the whitening function provided by the embodiment of the invention is convenient to carry, safe and reliable to eat, moderate in taste and special in fragrance, and can be directly poured into the mouth for taking; the astaxanthin direct drinking powder product with the whitening function provided by the invention has the advantages of easily available raw materials, simple preparation conditions and equipment, simple and controllable process and very important practical popularization value.
Finally, while the invention has been described in detail by way of general description and specific embodiments, it will be apparent to those skilled in the art that certain changes and modifications may be made thereto without departing from the scope of the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.
Claims (10)
1. The astaxanthin direct drinking powder composition with the whitening function is characterized by comprising the following components in parts by weight:
3-30 parts of astaxanthin microcapsule powder, 2-20 parts of haematococcus pluvialis powder, 0.2-10 parts of collagen peptide and 0.2-5 parts of ascorbic acid.
2. The astaxanthin drink powder composition according to claim 1, comprising the following components in parts by weight:
12-22.5 parts of astaxanthin microcapsule powder, 8.5-13.2 parts of haematococcus pluvialis powder, 0.75-3.6 parts of collagen peptide and 0.35-2.5 parts of ascorbic acid.
3. The astaxanthin drink-through powder composition according to claim 1 or 2, further comprising the following components in parts by weight:
5-45 parts of erythritol, 3-40 parts of orange powder, 3-35 parts of resistant dextrin, 2-15 parts of lemon powder, 0.2-5 parts of citric acid and 0.04-3 parts of edible essence.
4. An astaxanthin drink-through powder composition according to any one of claims 1 to 3, characterized by consisting of the following components in parts by weight:
30 parts of erythritol, 20 parts of orange powder, 20 parts of resistant dextrin, 15 parts of astaxanthin microcapsule powder, 10 parts of haematococcus pluvialis powder, 3 parts of lemon powder, 1 part of collagen peptide, 0.5 part of ascorbic acid, 0.5 part of citric acid and 0.1 part of edible essence.
5. An astaxanthin drink-through powder composition according to any one of claims 1 to 4, characterized in that the astaxanthin microcapsule powder consists of sodium starch octenyl succinate, Haematococcus pluvialis, isomaltooligosaccharide, ascorbic acid and sodium ascorbate, wherein the content of astaxanthin is 2.1-5.5 wt%.
6. An astaxanthin drink-through powder composition according to any one of claims 1-4, characterized in that the collagen peptide is polypeptide and oligopeptide substance which is obtained by enzymolysis of animal bones and fur and is rich in small molecules with the molecular weight of 700-5000 Da.
7. An astaxanthin drink-through powder composition according to any one of claims 1 to 4, characterized in that the content of astaxanthin in the Haematococcus pluvialis powder is 1.75-2.58 wt%.
8. An astaxanthin drink-through powder composition according to any one of claims 1-4, characterized in that the content of VC in the ascorbic acid is more than 95 wt%.
9. A method of preparing an astaxanthin drink-through powder composition according to any one of claims 1 to 8, comprising the steps of: mixing the above materials at a certain proportion, making into 60-80 mesh granules, drying, and packaging.
10. Use of an astaxanthin drink-through powder composition according to any one of claims 1 to 8 for the preparation of food, pharmaceutical or health care products with whitening effect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911184890.5A CN110743004A (en) | 2019-11-27 | 2019-11-27 | Astaxanthin direct drinking powder composition with whitening function and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911184890.5A CN110743004A (en) | 2019-11-27 | 2019-11-27 | Astaxanthin direct drinking powder composition with whitening function and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110743004A true CN110743004A (en) | 2020-02-04 |
Family
ID=69284834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911184890.5A Pending CN110743004A (en) | 2019-11-27 | 2019-11-27 | Astaxanthin direct drinking powder composition with whitening function and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110743004A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111363658A (en) * | 2020-03-05 | 2020-07-03 | 何凤霞 | A beverage containing Haematococcus pluvialis extract (astaxanthin) and its preparation method |
| CN111972584A (en) * | 2020-07-13 | 2020-11-24 | 荣成市森维迪生物科技有限公司 | Astaxanthin-containing anti-aging solid beverage |
| CN112494454A (en) * | 2020-12-04 | 2021-03-16 | 宁波泰一健康产业有限公司 | DHA-containing oral instant microcapsule powder and preparation method and application thereof |
| CN113261634A (en) * | 2021-06-16 | 2021-08-17 | 江苏格局生物医药科技有限公司 | Beverage process containing natural astaxanthin |
| CN114558117A (en) * | 2022-02-21 | 2022-05-31 | 沈阳药大生物科技有限公司 | Youth element composition for nourishing and beautifying and preparation method thereof |
| CN117562195A (en) * | 2023-12-07 | 2024-02-20 | 浙江索契壹营养科技有限公司 | Chinese and western compound beverage for whitening, removing freckles and resisting wrinkles, and preparation method and application thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050096556A (en) * | 2004-03-31 | 2005-10-06 | 정세영 | Skin whitening ingredients containing astaxanthin |
| JP2007320891A (en) * | 2006-05-31 | 2007-12-13 | Im Press Kk | Oral composition for promoting skin beauty |
| CN102335420A (en) * | 2011-10-19 | 2012-02-01 | 宁波红龙生物科技有限公司 | Composition containing haematococcus extract and collagen peptide and preparation method for composition |
| CN105581332A (en) * | 2015-12-31 | 2016-05-18 | 石家庄中硕药业有限公司 | Composition with skin moisture improving and antioxidation functions and preparation method |
| US20180168951A1 (en) * | 2015-06-26 | 2018-06-21 | Colltec Laboratories Limited | Formulation |
| CN108434443A (en) * | 2018-05-28 | 2018-08-24 | 广东康侨药业有限公司 | A kind of whitening antioxidation composition and application thereof |
| CN109662234A (en) * | 2019-01-17 | 2019-04-23 | 云南龙布瑞生物科技有限公司 | A kind of Astaxanthin In Haematococcus Pluvialis solid beverage adjusting women skin, anti-aging |
-
2019
- 2019-11-27 CN CN201911184890.5A patent/CN110743004A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050096556A (en) * | 2004-03-31 | 2005-10-06 | 정세영 | Skin whitening ingredients containing astaxanthin |
| JP2007320891A (en) * | 2006-05-31 | 2007-12-13 | Im Press Kk | Oral composition for promoting skin beauty |
| CN102335420A (en) * | 2011-10-19 | 2012-02-01 | 宁波红龙生物科技有限公司 | Composition containing haematococcus extract and collagen peptide and preparation method for composition |
| US20180168951A1 (en) * | 2015-06-26 | 2018-06-21 | Colltec Laboratories Limited | Formulation |
| CN105581332A (en) * | 2015-12-31 | 2016-05-18 | 石家庄中硕药业有限公司 | Composition with skin moisture improving and antioxidation functions and preparation method |
| CN108434443A (en) * | 2018-05-28 | 2018-08-24 | 广东康侨药业有限公司 | A kind of whitening antioxidation composition and application thereof |
| CN109662234A (en) * | 2019-01-17 | 2019-04-23 | 云南龙布瑞生物科技有限公司 | A kind of Astaxanthin In Haematococcus Pluvialis solid beverage adjusting women skin, anti-aging |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111363658A (en) * | 2020-03-05 | 2020-07-03 | 何凤霞 | A beverage containing Haematococcus pluvialis extract (astaxanthin) and its preparation method |
| CN111972584A (en) * | 2020-07-13 | 2020-11-24 | 荣成市森维迪生物科技有限公司 | Astaxanthin-containing anti-aging solid beverage |
| CN112494454A (en) * | 2020-12-04 | 2021-03-16 | 宁波泰一健康产业有限公司 | DHA-containing oral instant microcapsule powder and preparation method and application thereof |
| CN113261634A (en) * | 2021-06-16 | 2021-08-17 | 江苏格局生物医药科技有限公司 | Beverage process containing natural astaxanthin |
| CN114558117A (en) * | 2022-02-21 | 2022-05-31 | 沈阳药大生物科技有限公司 | Youth element composition for nourishing and beautifying and preparation method thereof |
| CN117562195A (en) * | 2023-12-07 | 2024-02-20 | 浙江索契壹营养科技有限公司 | Chinese and western compound beverage for whitening, removing freckles and resisting wrinkles, and preparation method and application thereof |
| CN117562195B (en) * | 2023-12-07 | 2024-10-15 | 浙江索契壹营养科技有限公司 | Chinese and western compound beverage for whitening, removing freckles and resisting wrinkles, and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110743004A (en) | Astaxanthin direct drinking powder composition with whitening function and preparation method and application thereof | |
| CN103501800B (en) | Beautiful-skin-promoting agent and use thereof | |
| RU2221456C1 (en) | Biologically active substance, biologically active supplement to food, pharmaceutical preparation, biologically active supplement for feeding animal, veterinary preparation, fertilizer, activator of microbiological process, oral nutrition, perfume-cosmetic agent, hygienic agent, dairy foodstuff, confectionery, baked goods, butter-fat foodstuff, sauce, alcohol drink, nonalcoholic beverage, piscine foodstuff, meat foodstuff, macaroni article, chewing gum, beer | |
| JP4163631B2 (en) | Fermentation composition of spicy varieties of chili pepper and its use | |
| CN103262992A (en) | Purple sweet potato milk pudding and processing method thereof | |
| CN101243824A (en) | Green pawpaw mastication tablet and producing method thereof | |
| KR20200089785A (en) | Antimicrobial emulsion compositon comprising yuja seed oil and yuja juice as an active ingredient, use thereof and method preparing the same | |
| CN104432074A (en) | Spirulina powder and preparation method thereof | |
| CN103444974A (en) | Red jujube tablet candy and preparation method thereof | |
| WO2018199231A1 (en) | Placenta extract | |
| JP5027361B2 (en) | Hyaluronic acid production promoter | |
| EP1656943A1 (en) | Extract from plant of japanese parsley family and process for producing the same | |
| JP5016535B2 (en) | Anti-aging food supplements and anti-aging agents | |
| CN103750094A (en) | Male hachinoko health-care paste and preparation method thereof | |
| TWI236909B (en) | Cell-activating agent | |
| JP2003284525A (en) | Method for improving solubility of polyphenol in water and aqueous solution containing high content of polyphenol | |
| CN111802498A (en) | High-heat-stability blueberry nutritional soft sweets with bone strengthening and health care effects and preparation method thereof | |
| JP2007197371A (en) | Beautiful skin promoter and beauty and health food | |
| JP2008280310A (en) | Promoter for forming and metabolizing testosterone | |
| CN103271353B (en) | Liver protecting and health care composition and preparation method thereof | |
| JP2002047193A (en) | Composition for prophylaxis or treatment of allergic dermatitis | |
| JP2003304845A (en) | Drink or food | |
| JP2001000146A (en) | Diet health food and diet health drink and cosmetic | |
| JP2005281272A (en) | Peripheral blood stream improving agent | |
| JP2012006905A (en) | Composition for skin care |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200204 |
|
| RJ01 | Rejection of invention patent application after publication |